Premium
The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide
Author(s) -
Walsh Martin P.,
Marshall Janice M.
Publication year - 2006
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.2006.108753
Subject(s) - dilator , medicine , endocrinology , hypoxia (environmental) , hyperventilation , vasodilation , calcitonin gene related peptide , nitric oxide , anesthesia , chemistry , oxygen , receptor , neuropeptide , organic chemistry
Experiments were performed under Saffan anaesthesia on normoxic (N) rats and on chronically hypoxic rats exposed to 12% O 2 for 1, 3 or 7 days (1, 3 or 7CH rats): N rats routinely breathed 21% O 2 and CH rats 12% O 2 . The 1, 3 and 7CH rats showed resting hyperventilation relative to N rats, but baseline heart rate (HR) was unchanged and arterial blood pressure (ABP) was lowered. Femoral vascular conductance (FVC) was increased in 1 and 3CH rats, but not 7CH rats. When 1–7CH rats were acutely switched to breathing 21% O 2 for 5 min, ABP increased and FVC decreased, consistent with removal of a hypoxic dilator stimulus that is waning in 7CH rats. We propose that this is because the increase in haematocrit and vascular remodelling in skeletal muscle help restore the O 2 supply. The increases in FVC evoked by acute hypoxia (8% O 2 for 5 min) and by infusion for 5 min of α‐calcitonin gene‐related peptide (α‐CGRP), which are NO‐dependent, were particularly accentuated in 1CH, relative to N rats. The NO synthesis inhibitor l ‐NAME increased ABP, decreased HR and greatly reduced FVC, and attenuated increases in FVC evoked by acute hypoxia and α‐CGRP, such that baselines and responses were similar in N and 1–7CH rats. We propose that in the first few days of chronic hypoxia there is tonic NO‐dependent vasodilatation in skeletal muscle that is associated with accentuated dilator responsiveness to acute hypoxia and dilator substances that are NO ‐dependent.